Area of research
Neurology · Cancer Research
Research interest
Research interests include Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Epigenetics and DNA Methylation, and FOXO transcription factor regulation.
Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma
5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor Phenotype
Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients
Identification of different<i>ALK</i>mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse
Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids
Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells
Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma
Truncated DNMT3B Isoform DNMT3B7 Suppresses Growth, Induces Differentiation, and Alters DNA Methylation in Human Neuroblastoma